| Factor Information | |
|---|---|
| Data ID | 3977 |
| Factor | Hand grip strength in kg |
| Description | Patients with a morphologic right system ventricle showed higher results (P=0.004) |
| Biomarker | NA |
| Classification | A6 (clinical factor - other) |
| Association | |
|---|---|
| Application | diagnosis and prognosis |
| Objective | To assess the degree of muscle dysfunction using Hand grip strength(HGS) as a biomarker in a large group of patients with CHD who often develop muscle dysfunction |
| p Value | 0.004 |
| Conclusion | Grip strength is an easily applicable, repeatedly usable and a cost-effective diagnostic tool to gain a quick, quantifiable assessment of the patient’s current muscle function as an expression of cardiac fitness. HGS is well suited to determine muscle function and strength and thereby to identify and to follow-up patients who have an increased cardiovascular risk. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 741 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | PA, VSD/TOF/DORV/PAA |
| Reference | |
|---|---|
| PMID | 31737527 |
| Year | 2019 |
| Title | The value of hand grip strength (HGS) as a diagnostic and prognostic biomarker in congenital heart disease |
| Sample | ||
|---|---|---|
| Population | adoleocents, adults | |
| Source | patients | |
| Region | Munich, Germany | |
| Method | HGS was measured according to a standardized protocol using a Jamar Hydraulic Hand Dynamometer (Jamar Hydraulic Hand Dynamometer Model 5030J1; Sammons Preston, Bolingbrook, IL, USA) | |
| Race | Eupopean | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | CHD with a morphologic right system ventricle(Treatment) | CHD(Control) |
| Number | N/A | N/A |
| Age | 27.6±13.1 years | 27.6±13.1 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 5.56 kg(95% CI: 1.75 to 9.37 kg) | 35.2±14.6 Kg |
